The two-edged sword: controlling hypertension without destroying the patient

ISSN： 0803-7051

Source： Blood Pressure, Vol.13, Iss.4, 2004-08, pp. : 212-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

When Blockade of the Renin-Angiotensin System Becomes a Two-Edged Sword

By Kurtz Theodore W.

American Journal of Hypertension, Vol. 26, Iss. 6, 2013-06 ,pp. : 721-722

Oxford University Press

Access to resources Recommend Favorite

Thrombocytopenia and thrombosis: a double-edged sword

By Nyo Myat Kalla Asgar

Clinical Rheumatology, Vol. 33, Iss. 4, 2014-04 ,pp. : 587-590

Springer Publishing Company

Access to resources Recommend Favorite

MICA Molecules in Disease and Transplantation, a Double-Edged Sword?

Current Immunology Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 307-325

Bentham Science Publishers

Access to resources Recommend Favorite

Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double –Edged Sword!

Recent Patents on Cardiovascular Drug Discovery, Vol. 9, Iss. 2, 2014-12 ,pp. : 73-77

Bentham Science Publishers

Access to resources Recommend Favorite

Glycaemic Control in Cardiac Surgery Patients: a Double-Edged Sword

Current Vascular Pharmacology, Vol. 13, Iss. 5, 2015-01 ,pp. : 578-586

Bentham Science Publishers

Access to resources Recommend Favorite